Leukemia & Lymphoma Society

December 23, 2021

New findings show that 43% of patients with certain blood cancers produced COVID-19 antibodies after receiving a third full dose of the mRNA vaccine.

October 21, 2021

An expert from the Leukemia & Lymphoma Society breaks down the effectiveness of the COVID-19 vaccine in patients with blood cancers on this episode of the “Cancer Horizons” podcast.

October 21, 2021

A three-time acute lymphoblastic leukemia survivor became a bone marrow transplant nurse and now helps other patients with the same diagnosis.

October 13, 2021

Patients with blood cancers may respond differently to doses of the COVID-19 vaccines based on the treatment they’re receiving, for example.

September 16, 2021

LLS Community is an online gathering place for patients, caregivers and healthcare professionals to share experiences and provide support.

September 15, 2021

Immune suppressing treatments — an essential component of many patients' cancer care — can blunt vaccine immune response.

September 15, 2021

Patients with relapsed/refractory, pretreated marginal zone lymphoma are now eligible for treatment with Brukinsa.

July 26, 2021

About 25% of patients with blood cancer did not produce antibodies after being vaccinated against COVID-19.

April 27, 2021

Patients with blood cancers are at a much higher risk of complications if they contract COVID-19, says an expert from the Leukemia & Lymphoma Society (LLS).

February 12, 2021

Blood shortages during the COVID-19 pandemic have forced cancer centers to get creative to ensure patients with hematologic malignancies are able to get transfusions in a timely manner.

September 10, 2020

Susan M. O’Brien, M.D., one of the nation’s foremost leukemia experts, discusses the future of frontline therapies and upcoming clinical trials associated with chronic lymphocytic leukemia.

August 25, 2020

August 25, 2020

August 25, 2020

August 25, 2020

June 12, 2020

From the American Cancer Society laying off 1,000 employees due to the economic impact of COVID-19 to former Senate Majority Leader Harry Reid announcing his cancer is in remission after receiving an experimental treatment, here’s what’s making the headlines in the cancer space this week.

April 22, 2020

Patients with blood cancers are facing unprecedented challenges to their treatment journeys as the COVID-19 pandemic continues to disrupt the cancer landscape. Which is why the Leukemia and Lymphoma Society is looking to offer its own lifeline to patients.

April 02, 2020

Two hematologist/oncologists on the LLS leadership team, and experts in the field of blood cancer, answer questions and concerns about coronavirus (COVID-19).

March 05, 2020

An expert sheds light on the latest therapies in clinical trials and promising drug combinations to thwart the aggressive disease.

February 07, 2020

February 07, 2020

February 07, 2020

February 07, 2020

February 07, 2020

September 19, 2019

Many patients with blood cancers may be candidates for autologous or allogeneic transplant.

May 16, 2017